BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Biologics

Jacobio Pharma Partners with Oceanpine Capital in RMB 200 Million Equity Deal for Cardiovascular Research Subsidiary

Jacobio Pharma announced that its subsidiary, Beijing Jacobio Pharmaceuticals Co., Ltd. ("Beijing Jacobio"), has entered into a Capital Increase and Equity...

October 16, 2025 | News

Clover Biopharmaceuticals Reports Promising Phase I Results for RSV+hMPV±PIV3 Combination Vaccines

Results indicate potential best-in-class RSV+hMPV±PIV3 combination vaccines, with the potential ability to re-vaccinate individuals previously...

October 15, 2025 | News

Mabwell’s CDH17-Targeting ADC 7MW4911 Receives NMPA IND Clearance for Advanced Solid Tumours

Mabwell (688062.SH), an innovative biopharmaceutical company with entire industry chain, announced that its self-developed CDH17-targeting ADC (R&D cod...

October 15, 2025 | News

Everest Medicines Secures Dual IND Approvals for EVM14, Its First Internally Developed Therapeutic mRNA Cancer Vaccine

EVM14 becomes Everest Medicines' internally developed therapeutic mRNA cancer vaccine to receive IND approvals from both China's National Medic...

October 14, 2025 | News

Lundbeck’s Bexicaserin Receives Breakthrough Therapy Designation in China for Severe Childhood Epilepsies

Accelerated pathway underscores urgent need for innovative solutions for patients with devastating, childhood-onset epilepsies Novel 5HT2C mechanism des...

October 14, 2025 | News

Thousand Oaks Biologics Secures EU QP Declaration for ADC Manufacturing Facility in Shanghai

Thousand Oaks Biologics' antibody-drug conjugate (ADC) manufacturing site successfully passed an audit conducted by a European Union Qualified Person ...

October 14, 2025 | News

Waters Launches Xevo™ CDMS to Redefine Mega-Mass Biomolecule Analysis

Xevo™ CDMS facilitates direct, accurate mass detection for the largest, most heterogeneous biomolecules. Enables accurate analysis of protein comp...

October 14, 2025 | News

South Korean Vaxcellbio Secures Australian Patent for Next-Generation NK Cell Expansion Technology

Vaxcellbio (CEO Je-Jung Lee, MD, PhD ), a biotechnology company specializing in immuno-oncology, announced ,that it has successfully obtained an Aust...

October 14, 2025 | News

Jenscare’s LuX-Valve Plus Approved for Use in Greater Bay Area Under Hong Kong-Macao Medicine and Equipment Connect

Jenscare Scientific Co., Ltd. ("Jenscare" or the "Company") (HKEX: 9877), an innovative medical device company with comprehensive structural heart disease ...

October 13, 2025 | News

Celltrion Receives FDA Approval for EYDENZELT®, a Biosimilar to EYLEA® for Retinal Diseases

EYDENZELT® is approved for the treatment of patients with neovascular (wet) age-related macular degeneration (wAMD), macular edema following ret...

October 13, 2025 | News

Leading Scientists Unite at OrganoAsia 2a025 to Advance Organoid Research and Industrial Applications

Leading Scientists from China, Japan and South Korea Convene to Drive Organoid Research and Commercialization ACROBiosystems, tog...

October 13, 2025 | Report

Asahi Kasei Expands Sonanos™ Portfolio with Two New Specialty Excipient Grades

Asahi Kasei, a trusted provider in healthcare materials and technology, announced that it will launch two new specialty grades in its Sonanos™ portfo...

October 13, 2025 | News

Ono Pharma Reports Positive Phase 2 Signals for ONO-2808 in Multiple System Atrophy

Efficacy signals were observed in an interim analysis of a Phase 2 clinical trial for ONO-2808, a S1P5 receptor agonist Phase 2 clinical trial was con...

October 13, 2025 | News

C-Ray Therapeutics Commends Biokin on NMPA Approval for Groundbreaking [177Lu]-BL-ARC001 Radiopharmaceutical

C-Ray Therapeutics (Chengdu) Co.,Ltd proudly congratulates its strategic partner, Biokin Pharmaceutical, on receiving implied approval from the N...

October 13, 2025 | News

Stay Connected